- Abstract:
-
Myeloid leukemia in Down syndrome (ML-DS) clonally evolves from transient abnormal myelopoiesis (TAM), a preleukemic condition in DS newborns. To define mechanisms of leukemic transformation, we combined exome and targeted resequencing of 111 TAM and 141 ML-DS samples with functional analyses. TAM requires trisomy 21 and truncating mutations in GATA1; additional TAM variants are usually not pathogenic. By contrast, in ML-DS, clonal and subclonal variants are functionally required. We identifi...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Publisher:
- Elsevier Publisher's website
- Journal:
- Cancer Cell Journal website
- Volume:
- 36
- Issue:
- 2
- Pages:
- 123-138.e10
- Publication date:
- 2019-07-11
- Acceptance date:
- 2019-06-11
- DOI:
- ISSN:
-
1535-6108
- Pubs id:
-
pubs:1031364
- UUID:
-
uuid:e17cd56b-7903-489b-bf90-a1c8a2092d4c
- Source identifiers:
-
1031364
- Local pid:
- pubs:1031364
- Language:
- English
- Keywords:
- Copyright holder:
- Elsevier Inc
- Copyright date:
- 2019
- Rights statement:
- © 2019 Elsevier Inc.
- Notes:
- This is the accepted manuscript version of the article. The publisher's version is available online
Journal article
Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with Down syndrome
Actions
Authors
Funding
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record